As MHC cell surface expression is indispensable for T cell interaction and the presentation of tumor derived peptides to helper T cells [8], [9], breast cancer cells likely down regulate MHC II genes to avoid immune recognition. The gene discussed is HLA-C; the disease is breast carcinoma.